Atlas Trials

RCT Cefiderocol vs BAT for Treatment of Gram Negative BSI

Clinical trial NCT03869437 · COMPLETED

Trial details

NCT number
NCT03869437
Sponsor
The University of Queensland
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Bloodstream Infections
Start date
2019-10-28
Primary completion
2023-11-13
Enrollment
513

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.